A current update on ADHD pharmacogenomics

Association Between Homozygosity of a G Allele of the Alpha-2a-Adrenergic Receptor Gene and Methylphenidate Response in Korean Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

(2009) Keun-Ah Cheon et al.   BIOLOGICAL PSYCHIATRY

Toward a New Understanding of Attention-Deficit Hyperactivity Disorder Pathophysiology

(2009) Amy F.T. Arnsten   CNS DRUGS

Candidate gene studies of ADHD: a meta-analytic review

(2009) Ian R. Gizer et al.   HUMAN GENETICS

Association of the catechol-O-methyltransferase polymorphism with methylphenidate response in a classroom setting in children with attention-deficit hyperactivity disorder

(2009) Keun-Ah Cheon et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

MAOA is associated with methylphenidate improvement of oppositional symptoms in boys with attention deficit hyperactivity disorder

(2009) Ana P. Guimarães et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Dopamine-Related Genotypes and the Dose–Response Effect of Methylphenidate on Eating in Attention-Deficit/Hyperactivity Disorder Youths

(2009) John J. Leddy et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Dopamine Transporter Genotype and Stimulant Side Effect Factors in Youth Diagnosed with Attention-Deficit/Hyperactivity Disorder

(2009) Reut Gruber et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Carboxylesterase 1 gene polymorphism and methylphenidate response in ADHD

(2009) Zsofia Nemoda et al.   NEUROPHARMACOLOGY

A Haplotype of the Norepinephrine Transporter (Net) Gene Slc6a2 is Associated with Clinical Response to Atomoxetine in Attention-Deficit Hyperactivity Disorder (ADHD)

(2009) Nicolas Ramoz et al.   NEUROPSYCHOPHARMACOLOGY

Two CES1 Gene Mutations Lead to Dysfunctional Carboxylesterase 1 Activity in Man: Clinical Significance and Molecular Basis

(2008) Hao-Jie Zhu et al.   AMERICAN JOURNAL OF HUMAN GENETICS

The impact of individual and methodological factors in the variability of response to methylphenidate in ADHD pharmacogenetic studies from four different continents

(2008) Guilherme Polanczyk et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Pharmacogenetics of methylphenidate response in attention deficit/hyperactivity disorder: Association with the dopamine transporter gene (SLC6A3)

(2008) D. Purper-Ouakil et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children

(2008) Eva Kereszturi et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Association between trypotphan hydroxylase 2, performance on a continuance performance test and response to methylphenidate in ADHD participants

(2008) Iris Manor et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder

(2008) Eric Mick et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Adrenergic α2A receptor gene and response to methylphenidate in attention-deficit/hyperactivity disorder-predominantly inattentive type

(2008) T. L. da Silva et al.   JOURNAL OF NEURAL TRANSMISSION

COMT Val 108/158 Met Polymorphism and the Modulation of Task-Oriented Behavior in Children with ADHD

(2008) Sarojini Sengupta et al.   NEUROPSYCHOPHARMACOLOGY

Association of dopamine, serotonin, and nicotinic gene polymorphisms with methylphenidate response in ADHD

(2007) Hema Tharoor et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Response to methylphenidate in adults with ADHD is associated with a polymorphism inSLC6A3 (DAT1)

(2007) J. Sandra Kooij et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

CYP2D6 metabolizer status and atomoxetine dosing in children and adolescents with ADHD

(2007) Paula T. Trzepacz et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY